Abstract:Ciprofol (HSK3486) is a novel intravenous agent for general anesthesia. In humans, HSK3486 mainly undergoes glucuronidation to form M4 [fraction of clearance (f CL ): 62.6%], followed by the formation of monohydroxylated metabolites that further undergo glucuronidation and sulfation to produce M5-1, M5-2, M5-3, and M3 (summed f CL : 35.2%). However, the complete metabolic pathways of HSK3486 in humans remain unclear. In this study, by comparison with chemically synthesized reference standards, three monohydroxylated metabolites [M7-1, 4-hydroxylation with an unbound intrinsic clearance (CL int,u ) of 2211 μ l/min/mg; M7-2, -hydroxylation with a CL int,u of 600 μ l/min/mg; and M7-3, (-1)-hydroxylation with a CL int,u of 78.4 μ l/min/mg] were identified in human liver microsomes, and CYP2B6 primarily catalyzed their formation. In humans, M7-1 was shown to undergo glucuronidation at the 4-position and 1-position by multiple UDP-glucuronosyltransferases (UGTs) to produce M5-1 and M5-3, respectively, or was metabolized to M3 by cytosolic sulfotransferases. M7-2 was glucuronidated at the position by UGT1A9, 2B4, and 2B7 to form M5-2. UGT1A9 predominantly catalyzed the glucuronidation of HSK3486 (M4). The CL int,u values for M4 formation in human liver and kidney microsomes were 1028 and 3407 μ l/min/mg, respectively. In vitro to in vivo extrapolation analysis suggested that renal glucuronidation contributed approximately 31.4% of the combined clearance. In addition to HSK3486 glucuronidation (M4), 4-hydroxylation (M7-1) was identified as another crucial oxidative metabolic pathway (f CL : 34.5%). Further attention should be paid to the impact of CYP2B6- and UGT1A9-mediated drug interactions and gene polymorphisms on the exposure and efficacy of HSK3486. SIGNIFICANCE STATEMENT This research elucidates the major oxidative metabolic pathways of HSK3486 (the formation of three monohydroxylated metabolites: M7-1, M7-2, M7-3) as well as definitive structures and formation pathways of these monohydroxylated metabolites and their glucuronides or sulfate in humans. This research also identifies major metabolizing enzymes responsible for the glucuronidation (UGT1A9) and oxidation (CYP2B6) of HSK3486 and characterizes the mechanism of extrahepatic metabolism. The above information is helpful in guiding the safe use of HSK3486 in the clinic.

Role of CYP hypotype on the metabolism of 629 in human liver microsomes in vitro

CYP450 1A2 and multiple UGT1A isoforms are responsible for jatrorrhizine metabolism in human liver microsomes.

In Vitro Metabolism of E2, G2: Novel Bile Acid-Coupling Camptothecin Analogues, in Rat Liver Microsomes

Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity

[CYP2D61, CYP2D610 Co-Expressed with CYPOR in Bac-to-Bac Expression System and Activity Determination].

Metabolite profiling and identification of enzymes responsible for the metabolism of hirsutine, a major alkaloid from Uncaria rhynchophylla

5-(Aziridin-1-yl)-3-hydroxymethyl-1-methylindole-4,7-dione: Its Cytotoxicity to HepG2 Cells and the Radiation Sensitizing Effect

Effect of recombinant CYP3A4 variants and interaction on imatinib metabolism in vitro

A Tryptophan Derivative, ITE, Enhances Liver Cell Metabolic Functions in Vitro

[Effect of Inducible Nitric Oxide Synthase on Tumour Cells Sensitivity to Mitomycin C Analogue 629 in Vitro].

Ite Enhances The Cyp450s Activities Of Rat Hepatocytes In A Bioreactor

Comparison of Catalytical Activity and Stereoselectivity Between the Recombinant Human Cytochrome P450 2D6.1 and 2D6.10.

Effect of Constitutive Androstane Receptor on Radiosensitization of Mictomycin C and Its Homologoue-629

Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice

Identification of Cytochrome P450s Involved in the Metabolism of 6-Benzyl-1-benzyloxymethyl-5-iodouracil (W-1) Using Human Recombinant Enzymes and Rat Liver Microsomes in Vitro.

Comparison of 1Beta- and 5Beta-hydroxylation of Deoxycholate and Glycodeoxycholate as In Vitro Index Reactions for Cytochrome P450 3A Activities

Cytochrome P450 2B6 and UDP-Glucuronosyltransferase Enzyme-Mediated Clearance of Ciprofol in Humans: The Role of Hepatic and Extrahepatic Metabolism

[Effect of Constitutive Androstane Receptor on the Cytotoxicity of Mitomycin C and 5-(Aziridin-1-yl)-3-hydroxymethyl-1-methylindole-4,7-dione].

CYP2A6 IS A PRINCIPAL ENZYME INVOLVED IN HYDROXYLATION OF 1,7-DIMETHYLXANTHINE, A MAIN CAFFEINE METABOLITE, IN HUMANS

Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2

The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6